Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Lung Neoplasms 5Colorectal Neoplasms 3Prostatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Hot Flashes 2Glioblastoma 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Brain Neoplasms 2Water-Electrolyte Imbalance 1Ventilator-Induced Lung Injury 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Severe Acute Respiratory Syndrome 1Rectal Neoplasms 1Postoperative Complications 1Pathologic Complete Response 1Neoplasm, Residual 1Mastocytosis 1Lymphopenia 1Lymphoma, Non-Hodgkin 1Lymphedema 1Lower Urinary Tract Symptoms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Hypersensitivity 1

Interventions

Control Groups 2Atorvastatin 2sacubitril and valsartan sodium hydrate drug combination 1pertuzumab 1nicotinamide-beta-riboside 1empagliflozin 1dapagliflozin 1candesartan 1Trastuzumab 1Sodium Chloride 1Simendan 1Pyruvic Acid 1Population Groups 1Ogivri 1Metoprolol 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Eplerenone 1Carvedilol 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Heart Failure × Sodium Chloride × Clear all
NCT03557255 2018-06-14

Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer Surgeries

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡